Results 261 to 270 of about 6,255,404 (306)
Some of the next articles are maybe not open access.

Pharmacology and clinical pharmacology of organic nitrates

European Journal of Clinical Pharmacology, 1990
Current concepts and future aspects of pharmacological interventions in the treatment of coronary heart disease have been compiled. Especially new insights in the pathophysiology of coronary heart disease e.g. the dynamic pathology of coronary atherosclerosis, possible role of endothelin in vasospasm, as well as new pharmacodynamic and pharmacokinetic ...
openaire   +2 more sources

Clinical pharmacology in Nigeria

Clinical Pharmacology & Therapeutics, 1974
Nigeria, today, with a strongly developing economy, is laying the fQUndation for future achievement. While there is no specific unit of clinical pharmacology yet in the country, the principle is recognized and the need appreciated. There are many features in Nigeria that, if properly appreciated and utilized, will aid the progression of clinical ...
openaire   +2 more sources

Clinical Pharmacology of Digoxin

Pediatric Clinics of North America, 1972
Although digoxin is invaluable for a variety of cardiovascular diseases, and it is virtually the only cardiac glycoside in common use today in children and infants, it is known to have a low margin of safety. A central goal of this paper is to aid the education of clinicians so as to alter a traditional mode of administering digoxin, that of pushing to
openaire   +2 more sources

Clinical Pharmacology of Lacidipine

Journal of Cardiovascular Pharmacology, 1991
The safety and tolerability of lacidipine was assessed in a volunteer population, and its pharmacodynamic and pharmacokinetic profiles evaluated. In normotensive subjects, single oral doses of 3-5 mg of lacidipine produced a dose-related fall in peripheral vascular resistance.
S T, Hall   +4 more
openaire   +2 more sources

Clinical Pharmacology and Adolescence

Pediatric Clinics of North America, 1980
When determining the type and timing of drug therapy for adolescents, certain biological and psychosocial factors unique to this age group must be considered. Modern drug monitoring techniques allow the physician to more successfully treat the adolescent patient.
openaire   +2 more sources

Clinical pharmacology

Medical Journal of Australia, 1961
Gillian M, Shenfield   +2 more
openaire   +2 more sources

Clinical Pharmacology of Famotidine

Digestion, 2009
The results of the initial clinical pharmacology studies of famotidine, a new H<sub>2</sub> receptor antagonist, are summarized. These studies indicate that: (1) single oral doses of famotidine (5–80 mg) were well tolerated; (2) famotidine effectively suppressed basal, nocturnal, pentagastrin- and meal-stimulated acid secretion; (3) the ...
openaire   +2 more sources

Clinical Pharmacology of Nicotine

Annual Review of Medicine, 1986
Nicotine is the primary reason why people consume tobacco products and it may contribute to causation of tobacco-related diseases. This chapter reviews the human pharmacology of nicotine, the evidence for a role of nicotine in human disease, and the use of nicotine (gum) as a therapeutic agent in smoking cessation therapy.
openaire   +2 more sources

Clinical Pharmacology of Valpromide

Clinical Pharmacokinetics, 1991
Valpromide has been used as an antiepileptic and antipsychotic drug for the past 25 years in several European countries. Unlike its corresponding acid, valproic acid, whose pharmacokinetics have been quite extensively reviewed, and despite years of clinical use, it appears that no reviews have been written on the pharmacokinetics of valpromide.
openaire   +2 more sources

Home - About - Disclaimer - Privacy